JDD Buzz Series | The Burden of Melasma
A study in the August Journal of Drugs in Dermatology addressed the burden of melasma – the populations most prone to melasma and the comorbidities associated with it. According to the study’s authors, a deeper understanding of the associations of race, ethnicity and comorbidities can help dermatologists determine which patients are at risk of developing melasma and as well as potential new pa …
A study in the August Journal of Drugs in Dermatology addressed the burden of melasma – the populations most prone to melasma and the comorbidities associated with it. According to the study’s authors, a deeper understanding of the associations of race, ethnicity and comorbidities can help dermatologists determine which patients are at risk of developing melasma and as well as potential new pa … 
TikTok is a source of beauty and skin health information for the masses. Yet much of the content is not produced by board-certified dermatologists or even other healthcare professionals. So who’s creating TikTok content about sun protection and skin cancer? Does any of this content address skin of color? Those are the questions a new cross-sectional analysis published in the July Journal of Drug … 
Sunscreen use varies among different racial groups despite its scientifically proven benefits. A cross-sectional, questionnaire-based study in the June issue of the Journal of Drugs in Dermatology aims to understand the needs and challenges people with skin of color face when choosing and using sunscreen.
I interviewed author Jared Jagdeo, MD, MS, associate professor of dermatology and director … 
Mohs Micrographic Surgery effectively removes skin cancer while preserving healthy tissue. But what happens when the procedure that’s supposed to help maintain aesthetics leads to long-lasting and highly distressing cosmetic outcomes?
That’s the focus of an observational study published in the May issue of the Journal of Drugs in Dermatology. Researchers looked at the factors that contribut … 
Tranexamic acid is one of the latest therapies for treating melasma, and one that’s most commonly prescribed for women. An editorial published in the April issue of the Journal of Drugs in Dermatology encourages dermatology clinicians to also consider the effect melasma has on men and to utilize tranexamic acid as a treatment option.
I interviewed the authors, dermatologist and Mohs surgeon A …